Loteprednol etabonate/tobramycin vs tobramycin/dexamethasone in Chinese patients with ocular inflammation associated with blepharokeratoconjunctivitis.

Trial Profile

Loteprednol etabonate/tobramycin vs tobramycin/dexamethasone in Chinese patients with ocular inflammation associated with blepharokeratoconjunctivitis.

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Loteprednol etabonate/tobramycin (Primary) ; Tobramycin/dexamethasone
  • Indications Bacterial infections; Blepharoconjunctivitis; Keratoconjunctivitis
  • Focus Therapeutic Use
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 23 Apr 2013 Last checked against ClinicalTrials.gov record.
    • 27 Feb 2012 New source identified and integrated (NCT01028027; ClinicalTrials.gov: US National Institutes of Health).
    • 03 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top